Pfizer Slumps as Two Firms Downgrade on Mylan Deal Impact

(Bloomberg) -- Pfizer Inc. was hit with a pair of downgrades on Tuesday as analysts cautioned over the impact that the company’s recently announced deal with Mylan NV would have on the stock.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.